ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000273162.1	Avagacestat	Bladder urothelial carcinoma	0.021048527	Resistant
ENSG00000273162.1	Avagacestat	Head and neck squamous cell carcinoma	0.005898422	Resistant